Markus D Siegelin

Associate Professor of Pathology and Cell Biology · Vagelos College of Physicians and Surgeons

Credentials: · ·

History

HDAC Inhibitors Reverse the Warburg Effect and Elicit Metabolic Vulnerabilities in Model Systems of Glioblastoma
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $2M · Columbia University Health Sciences
2021–2026
Targeting OGDH for Glioblastoma Therapy
National Institute of Neurological Disorders and Stroke · R21
Contact PI · $452.4K · Columbia University Health Sciences
2024–2026
Targeting Mutant IDH1 for a Novel Synthetic Lethal Interaction in Malignant Gliomas
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $1.8M · Columbia University Health Sciences
2018–2024
Dual Inhibition of Mitochondrial Matrix Chaperones and Anti-Apoptotic Bcl-2 Family Members for Glioblastoma Therapy.
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $1.8M · Columbia University Health Sciences
2016–2022